4//SEC Filing
Lundy Steve 4
Accession 0001079973-12-000315
CIK 0001167419other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 5:22 PM ET
Size
5.6 KB
Accession
0001079973-12-000315
Insider Transaction Report
Form 4
Lundy Steve
DirectorCEO and President
Transactions
- Award
Stock Option (Right to Buy)
2012-04-30+75,000→ 75,000 totalExercise: $0.66Exp: 2022-04-30→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The option to purchase 75,000 shares of common stock shall become exercisable as to 50% of the shares on October 30, 2012, as to 8.33% of the shares on November 30, 2012, as to 8.33% of the shares on December 31, 2012, as to 8.33% of the shares on January 31, 2013, as to 8.33% of the shares on February 28, 2013, as to 8.34% of the shares on March 31, 2013, and as to 8.34% of the shares on April 30, 2013.
Documents
Issuer
AspenBio Pharma, Inc.
CIK 0001167419
Entity typeother
Related Parties
1- filerCIK 0001408113
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 5:22 PM ET
- Size
- 5.6 KB